“…These cells have several limitations that introduce induced pluripotent stem cells (iPSCs), which could be derived from epithelial cells with overexpression of the four transcription factors, which are specifically for embryonic stage (Ardeshirylajimi, ; Takahashi & Yamanaka, ). These iPSCs can be differentiated into neurons (Salimi, Nadri, Ghollasi, Khajeh, & Soleimani, ), heart muscle (Takahashi et al, ), cartilage (Mahboudi et al, ), bone (Ardeshirylajimi & Soleimani, ), hepatocytes (Mahmoodinia Maymand et al, ), and insulin producing cells (Mansour et al, ). These cells have the same differentiation potential as that of embryonic stem cells (ESCs), but without its ethical issues, and as these cells are taken from the patient themselves, the rejection percentage of the transplant is zero; also, its potential is not age‐dependent and is increased in adult stem cells (Hwang et al, ; Jung, ).…”